Specifically, by interacting with TBK1, mutant p53 inhibits downstream cGAS-STING cytoplasmic DNA sensing signaling pathway, leading to an inhibited type I IFN response and promoting tumor growth through immune evasion. Here, TP53 is linked to neoplasm.